JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,000 | -11.9% | 8,631 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $98,806 | -1.4% | 8,324 | +0.5% | 0.00% | 0.0% |
| Q1 2023 | $100,212 | -6.3% | 8,282 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $106,914 | -2.8% | 8,118 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $110,000 | +12.2% | 8,147 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $98,000 | -22.2% | 8,032 | -8.9% | 0.00% | 0.0% |
| Q1 2022 | $126,000 | -9.4% | 8,813 | +25.3% | 0.00% | 0.0% |
| Q4 2021 | $139,000 | -11.5% | 7,031 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $157,000 | – | 7,242 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $117,401,000 | 2.50% |
| 5AM Venture Management, LLC | 446,266 | $6,042,000 | 1.16% |
| Samsara BioCapital, LLC | 360,414 | $4,880,000 | 1.14% |
| BVF INC/IL | 1,470,334 | $19,908,000 | 0.82% |
| Orbimed Advisors | 2,836,386 | $38,405,000 | 0.71% |
| EcoR1 Capital, LLC | 1,421,319 | $19,245,000 | 0.57% |
| Woodline Partners LP | 400,181 | $5,418,000 | 0.08% |
| Parkwood LLC | 33,352 | $452,000 | 0.07% |
| JANUS HENDERSON GROUP PLC | 3,920,088 | $26,572,546 | 0.02% |
| Cerity Partners LLC | 105,933 | $1,434,000 | 0.02% |